Expand all sections

Tislelizumab

Extended indication Extension of indication to include in combination with platinum-based chemotherapy the first-line tr
Therapeutic value No estimate possible yet
Registration phase Positive CHMP opinion

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information